Overall survival | Disease-free survival | |||||
---|---|---|---|---|---|---|
Variables | HR | CI95% | P-value | HR | CI95% | P-value |
FBL | ||||||
Intermediate | 1.00 | 0.0042* | 1.00 | 0.0149* | ||
Low | 2.35 | [1.41–3.92] | 2.02 | [1.21–3.39] | ||
High | 1.27 | [0.72–2.24] | 1.56 | [0.94–2.56] | ||
NOP58 | ||||||
Low | removed | removed | ||||
High | ||||||
Tumor size | ||||||
< 30 mm | 1.00 | < 0.0001*** | 1.00 | 0.0002** | ||
≥ 30 mm | 2.77 | [1.77–4.33] | 2.14 | [1.44–3.18] | ||
Lymph node invasion status | ||||||
N = 0 | 1.00 | 0.0443* | 1.00 | 0.0174* | ||
N ≥ 1 | 1.61 | [1.01–2.55] | 1.64 | [1.09–2.48] | ||
Breast cancer subtypes | ||||||
ER + PR ± HER2- | 1.00 | 0.0463* | N/A | N/A | ||
ER ± PR ± HER2 + | 1.06 | [0.63–1.79] | ||||
ER- PR- HER2- | 1.94 | [1.12–3.35] |